Literature DB >> 15883801

The time-course of ribavirin-provoked changes of basal and AMPH-induced motor activities in rats.

Branka Janać1, Vesna Pesić, Sanja Peković, Ljubisav Rakić, Mirjana Stojiljković.   

Abstract

The time-course of changes of basal and amphetamine (AMPH)-induced locomotor and stereotypic activities in adult male Wistar rats after a single ribavirin injection was studied. In the first set of experiments, 10, 20 or 30 mg ribavirin/kg body weight (b.w.) were injected i.p. to rats and their basal motor activities were recorded every 10 min for 2 h and compared with those of saline-treated controls. In the second set of experiments, the animals were pretreated with ribavirin and 20 min later i.p. injected with AMPH (1.5 mg/kg b.w.). The controls received AMPH 20 min after the saline injection. Motor activity was recorded after the first injection and until 120 min after AMPH administration. Ribavirin did not significantly affect the time-course of either basal locomotor or stereotypic activities. Pretreatment with any of the applied ribavirin doses decreased the AMPH-induced hyperlocomotor response. However, the most pronounced effect was observed with ribavirin doses of 20 mg/kg and 30 mg/kg when administered during the first 10 min and 30 min after the AMPH injection respectively. In contrast, the stereotypic activities of these animals were only slightly changed. These results indicate a different susceptibility of regions in the basal ganglia to ribavirin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883801     DOI: 10.1007/s00221-005-2311-0

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  32 in total

1.  Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia.

Authors:  R D Mayfield; B A Jones; H A Miller; J K Simosky; G A Larson; N R Zahniser
Journal:  Synapse       Date:  1999-09-15       Impact factor: 2.562

2.  Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites.

Authors:  S Ferre; P Popoli; B Tinner-Staines; K Fuxe
Journal:  Neurosci Lett       Date:  1996-04-19       Impact factor: 3.046

3.  The cellular localization of adenosine receptors in rat neostriatum.

Authors:  S P Alexander; M Reddington
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

Review 4.  A psychomotor stimulant theory of addiction.

Authors:  R A Wise; M A Bozarth
Journal:  Psychol Rev       Date:  1987-10       Impact factor: 8.934

5.  A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Pharmacol Biochem Behav       Date:  1985-09       Impact factor: 3.533

6.  The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain.

Authors:  S Ferré; W T O'Connor; K Fuxe; U Ungerstedt
Journal:  J Neurosci       Date:  1993-12       Impact factor: 6.167

Review 7.  Amphetamine: effects on catecholamine systems and behavior.

Authors:  L S Seiden; K E Sabol; G A Ricaurte
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

8.  Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats.

Authors:  E Poleszak; D Malec
Journal:  Pol J Pharmacol       Date:  2000 Nov-Dec

9.  Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus.

Authors:  B E Gilbert; P R Wyde; S Z Wilson; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

10.  NECA-induced hypomotility in mice: evidence for a predominantly central site of action.

Authors:  M J Durcan; P F Morgan
Journal:  Pharmacol Biochem Behav       Date:  1989-02       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.